Inflammatory bowel disease in Korea: epidemiology and pathophysiology
Open Access
- 29 July 2022
- journal article
- review article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 37 (5), 885-894
- https://doi.org/10.3904/kjim.2022.138
Abstract
Inflammatory bowel disease (IBD) refers to a group of disorders, including Crohn's disease and ulcerative colitis, that exhibit similar but distinct manifestations. These diseases are characterized by refractory and chronic inflammation of the bowel. IBD is usually accompanied by severe symptoms. When a patient presents with suspected IBD, physicians encounter various challenges in terms of diagnosis and treatment. In addition, given such characteristics, the associated medical expenses gradually increase. Although IBD was formerly known as a disease of Western countries, the incidence and prevalence are increasing in Korea. Korean investigators have accumulated a great deal of knowledge about the regional characteristics and epidemiology of the disease, especially via well-organized, joint cohort studies. Against this background, this article describes the epidemiology of IBD in Korea compared to that in the West. In addition, an overview of the pathophysiology of the disease is provided, focusing on the latest results.Keywords
This publication has 85 references indexed in Scilit:
- Long-term Clinical Outcomes of Urban Versus Rural Environment in Korean Patients with Crohn's Disease: Results from the CONNECT StudyJournal of Crohn's and Colitis, 2015
- Molecular regulation of effector and memory T cell differentiationNature Immunology, 2014
- Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-PacificGut, 2014
- The IL-23–IL-17 immune axis: from mechanisms to therapeutic testingNature Reviews Immunology, 2014
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future AheadGastroenterology, 2014
- Severe Disease Activity and Cytomegalovirus Colitis Are Predictive of a Nonresponse to Infliximab in Patients with Ulcerative ColitisDigestive Diseases and Sciences, 2013
- Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseasesInflammatory Bowel Diseases, 2012
- Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitisGut, 2011
- Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in IntestineCell, 2010
- Clinical features and long-term prognosis of Crohn's disease in KoreaScandinavian Journal of Gastroenterology, 2010